MedAccess

Public agencies in over 100 LMICs will be able to buy SD Biosensor’s STANDARD Q HIV/Syphilis Combo test for less than $1 through a collaboration between the company, the Clinton Health Access Initiative (CHAI) and Britain’s MedAccess, the partners announced Monday.

A volume guarantee agreement between MedAccess and the South Korean manufacturer will make the WHO-prequalified diagnostic available to a cohort of countries bearing 98% of the global burden of congenital syphilis and 93% of…

In a three-way financing agreement announced Wednesday, Gavi will fund GSK’s continued manufacturing of the antigen for the British pharma company’s RTS,S/AS01e malaria vaccine, pending a WHO decision expected later this year on whether to recommend the shot for broader use.

If WHO does endorse and Gavi’s board approves a malaria vaccination program, GSK would then credit the value of the Gavi-funded costs toward procurement of finished doses, according to a joint press release.…

The state of the hunt:

Vaccine candidates from Bharat Biotech, Medicago, Zydus Cadila and the University of Queensland entered Phase 1 or 1/2 trials this week.
  Inactivated candidates from CNBG entered Phase 3.
  India issued emergency approval of Biocon’s itolizumab for the treatment of coronavirus-related cytokine-release syndrome.

 

Vaccines

Clinical trials:

Moderna says 30,000-participant Phase 3 trials of its investigational mRNA vaccine…

Britain’s Department for International Development, Unitaid, the British government’s MedAccess, the Clinton Health Access Initiative (CHAI), the U.S. President’s Emergency Plan for AIDS Relief, the African Society for Laboratory Medicine, and the government of Zambia announced a deal at last week’s International AIDS Conference with Massachusetts-based Hologic Inc. to provide public sector programs in eligible countries with its molecular diagnostics for a single, all-inclusive price per…